Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
October 26, 2023 at 06:32 AM EDT
Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|